As we all know there is a phase in the development of this pathology that makes its course deadly: when cancer cells multiply and spread to other organs, creating metastases, it is almost impossible to face and win the battle for a patient's survival. The recent studies by Waisman have identified in this process the direct responsibilities of a protein, S100A10, present on the surface of macrophages, the cells responsible for the body's immune defense.
The action of this protein, in practice, would 'break the boundaries' between the tumor and the healthy cells of the organism, allowing it to spread throughout the body. Understanding how S100A10 works (this is the next step in this research that could lead to truly definitive and historical results) could lead to the development of drugs capable of inhibiting its action, thus preventing the creation of metastases.
The results of this experimental study were also observed on guinea pigs: compared to two mice, one with and one with S100A10 deficiency (unfortunately inoculated with fibrosarcomas to proceed with the study), the mouse with deficiency of the key-protein showed, after washing peritoneal and analysis of the collected macrophages, the absence of cancer proliferation and regression of the injected tumor tissue.
It is possible to expect man's victory over Cancer: it is not a question of IF, but of WHEN. The future in which, struck by a tumor, anyone can keep it at bay like a hernia or a chronic discomfort is not far off, simply by taking a drug.
Today we arm ourselves with more patience, and with new hope.